Gadolinium Lawyer

An elderly man in Northern California has sued various health companies after he contracted an incurable disease due to the dyes used in an MRI.
Around 215 cases of gadolinium causing nephrogenic systemic fibrosis or nephrogenic fibrosing demopathy have been reported worldwide. No cures have been found but some patients see improvement in their condition after treatments.
The FDA issued […]

[Read more →]

Gadolinium based contrast agents that are used in MRIs have been linked with Nephrogenic Systemic Fibrosis(NSF)/Nephrogenic Fibrosing Dermopathy (NFD) in patients with kidney disease. Recently, the FDA released information that suggests MRAs, a variation of MRIs, that use gadolinium based contrast agents may pose more of a risk of causing NSF than they do in traditional […]

[Read more →]

As of May 23, 2007 the U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI).Warnings would state that patients with severe kidney insufficiency who receive gadolinium-based agents are […]

[Read more →]

Manufacturers of Gadolinium-based contrast agents issued a Dear Healthcare Professional letter to inform healthcare professionals of the addition of a BOXED WARNING and revisions to the WARNING section of the prescribing information for Gadolinium-based contrast agents used in Magnetic Resonance Imaging (MRI).The text of the letter is as follows:Dear Healthcare Professional,
The manufacturers of gadolinium-based contrast […]

[Read more →]

Gadolinium (chemical symbol “Gd”) is a chemical element listed on the Periodic Table.  It was named after the Finnish chemist John Gadolin  (1760-1852) to honor his research in rare earth metals.   Gadolinium is a silvery-white rare metal which occurs naturally on Earth and is relatively stable in dry air unlike other s of that classification.  […]

[Read more →]